The Oral Bioavailability market is a subset of the Drug Delivery market, which focuses on the delivery of drugs to the body through various means. Oral bioavailability is the measure of how much of a drug is absorbed into the bloodstream when taken orally. This is important for drug efficacy, as it determines how much of the drug is available to the body for therapeutic use.
Oral bioavailability is affected by a variety of factors, including the drug's solubility, permeability, and metabolism. To improve bioavailability, drug delivery systems such as liposomes, nanoparticles, and microemulsions are used to increase the drug's solubility and permeability.
Companies in the Oral Bioavailability market include Novartis, Pfizer, Merck, and AstraZeneca. Other companies include GlaxoSmithKline, Sanofi, and Johnson & Johnson. Show Less Read more
